Versono Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 28

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4.26M

  • Investors
  • 9

Versono General Information

Description

Operator of a medical device company intended to transform intravascular treatment for critical limb ischemia patients. The company is commercializing a disruptive vascular device technology platform to address a well-understood need and limiting factor in the growth of endovascular surgery, enabling the healthcare industry to work with an alternative technology in the endovascular treatment of complex lesions in the peripheral vasculature.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Parkmore Business Park West
  • Galway H91 HP4F
  • Connaught
  • Ireland
+353 087
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Biotechnology
Corporate Office
  • Parkmore Business Park West
  • Galway H91 HP4F
  • Connaught
  • Ireland
+353 087

Versono Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Versono Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 28-Aug-2026 $4.26M Completed Generating Revenue
6. Grant 15-Apr-2025 Completed Product In Beta Test
5. Accelerator/Incubator 11-Jan-2023 Completed Product In Beta Test
4. Early Stage VC 06-Apr-2022 Completed Product In Beta Test
3. Secondary Transaction - Private Completed Product In Beta Test
2. Early Stage VC 22-Sep-2020 $18.8K $4.52M Completed Product In Beta Test
1. Early Stage VC 30-Jun-2019 $4.5M $4.5M Completed Product In Beta Test
To view Versono’s complete valuation and funding history, request access »

Versono Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 1,516,000 $0.000000 $0.03 $0.03 1x $0.03 46.8%
Ordinary 187,217 $0.000000 $0.01 $0.01 1x $0.01 5.78%
To view Versono’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Versono Patents

Versono Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202501800-D0 Acoustic drug delivery catheter Inactive 06-Feb-2025
WO-2026167213-A1 Systems and methods for intravascular treatment Pending 06-Feb-2025
GB-202501801-D0 Ultrasonic waveguide mediated intra vascular lithotripsy for balloon angioplas Pending 06-Feb-2025
GB-202416068-D0 Differential activation retention tube ultrasonic coupling insert for ultrasonically actuated waveguide Inactive 31-Oct-2024
WO-2026093564-A1 Improvements in or relating to ultrasonic endovascular apparatus Pending 31-Oct-2024 A61B17/22012
To view Versono’s complete patent history, request access »

Versono Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Versono Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Moore Global Corporation Minority
Western Development Commission Venture Capital Minority
Dragons Den Angel Group
European Innovation Council Accelerator/Incubator Minority
Horizon Europe Not-For-Profit Venture Capital
You’re viewing 5 of 9 investors. Get the full list »

Versono FAQs

  • When was Versono founded?

    Versono was founded in 2018.

  • Where is Versono headquartered?

    Versono is headquartered in Galway, Ireland.

  • What is the size of Versono?

    Versono has 28 total employees.

  • What industry is Versono in?

    Versono’s primary industry is Therapeutic Devices.

  • Is Versono a private or public company?

    Versono is a Private company.

  • What is Versono’s current revenue?

    The current revenue for Versono is .

  • How much funding has Versono raised over time?

    Versono has raised $18.8M.

  • Who are Versono’s investors?

    Moore Global, Western Development Commission, Dragons Den, European Innovation Council, and Horizon Europe are 5 of 9 investors who have invested in Versono.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process